TIANJIN DEV: Completion of Share Repurchases and Adoption of Share Award Scheme by a Listed Subsidiary
TIANJIN DEV: Discloseable Transactions - Proposed Share Repurchase(s) and Proposed Adoption of Share Award Scheme by a Listed Subsidiary
TIANJIN DEV: Renewal of Existing Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd. and Notice of Extraordinary General Meeting
TIANJIN DEV: Renewal of Existing Continuing Connected Transactions and Entering Into of New Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd.
TIANJIN DEV: Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd.
TIANJIN DEV: Discloseable Transaction - Subscription of Wealth Management Product
TIANJIN DEV: Continuing Connected Transactions - Products Procurement Master Agreement and Integrated Services Master Agreement
TIANJIN DEV: Discloseable Transaction - Disposal of 24.65% Equity Interest in Tianjin Tanabe Seiyaku Co., Ltd.
TIANJIN DEV: Discloseable Transaction - Subscription of Wealth Management Products
TIANJIN DEV: Material Variation of the Terms of Connected Transaction in relation to the Partnership Agreement
TIANJIN DEV: Supplemental Announcement in relation to Connected Transaction Formation of Limited Partnership Fund
TIANJIN DEV: Discloseable Transaction - Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.
TIANJIN DEV: Connected Transaction - Formation of Limited Partnership Fund
TIANJIN DEV: Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary General Meeting
TIANJIN DEV: Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: Discloseable Transacttion - Resumption of the Properties held by Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: Connected Transaction - Subscription of Wealth Management Product
TIANJIN DEV: Disposal of Properties and Ancillary Equipment held by Tianjin Biochemical Pharmaceutical Co., Ltd.
TIANJIN DEV: Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement and Notice of Extraordinary General Meeting
TIANJIN DEV: Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement